---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-26-003119"
form_type: "8-K"
ticker: "MBRX"
cik: "0001659617"
company_name: "Moleculin Biotech, Inc."
filed_at: "2026-02-05T23:59:59+00:00"
generated_at: "2026-05-16T04:28:09.780380+00:00"
event_type: "other"
sentiment: "negative"
materiality_score: 0.3
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Moleculin Biotech shareholders approve warrant share issuance, reject name change to Moleculin Inc.

## Summary
- Approved issuance of up to 2,610,823 shares upon exercise of warrants issued Dec 11, 2025; 578,385 For, 68,176 Against.
- Name change amendment from Moleculin Biotech, Inc. to Moleculin Inc. failed: 1,124,921 For (needed >1,346,766 majority of outstanding shares).
- Adjournment proposal approved (582,534 For, 64,190 Against) to allow further proxy solicitation if needed.

## SEC filing metadata
- accession: 0001437749-26-003119
- form_type: 8-K
- ticker: MBRX
- cik: 0001659617
- company_name: Moleculin Biotech, Inc.
- filed_at: 2026-02-05T23:59:59+00:00
- event_type: other
- sentiment: negative
- materiality_score: 0.3
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1659617/000143774926003119/0001437749-26-003119-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1659617/000143774926003119/mbrx20260204_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-26-003119
- JSON: https://secwatch.observer/filing/0001437749-26-003119.json
- Plain text: https://secwatch.observer/filing/0001437749-26-003119.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.